CT features of lung disease in patients with systemic scerosis: Comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia

Radiology

Volumn 232, Issue 2, 2004, Pages 560-567

  Desai, Sujal R ^a   Veeraraghavan, Srihari ^b   Hansell, David M ^b   Nikolakopolou, Ageliki ^b   Goh, Nicole S L ^b   Nicholson, Andrew G ^b   Colby, Thomas V ^c   Denton, Christopher P ^d   Black, Carol M ^d   Du Bois, Roland M ^b   Wells, Athol U ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c MAYO CLINIC   (United States)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Lung, CT; Lung, diseases; Lung, fibrosis; Lung, interstitial disease; Pneumonia, nonschedule interstitial and fibrosis; Pneumonia, usual interstitial; Scleroderma

Indexed keywords

CARBON MONOXIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EVALUATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG EMPHYSEMA; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 3242813602     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2322031223     Document Type: Article

References (40)

1. Piper WN, Helwig EB. Progressive systemic sclerosis: visceral manifestations in generalized scleroderma. AMA Arch Derm 1955; 72:535-546.
2. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46:428-440.
3. Harrison NK, Myers AR, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991; 144:706-713.
4. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment-international consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). I. Am J Respir Crit Care Med 2000; 161:646-664.
5. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165:277-304.
6. Fujita J, Yoshinouchi T, Ohtsuki Y, et al. Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis. Ann Rheum Dis 2001; 60:281-283.
7. Kim DS, Yoo B, Lee JS, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19:121-127.
8. Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165:1581-1586.
9. Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164:193-196.
10. Cherniack RM, Colby TV, Flint A, et al. Co-operative group steering committee, 1991: quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991; 144:892-900.
11. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988; 41:467-470.
12. MacDonald SL, Rubens MB, Hansell DM, et al. Non-specific interstitial pneumonitis and usual interstitial pneumonitis: comparative appearances and diagnostic accuracy of high resolution computed tomography. Radiology 2001; 221:600-605.
13. Park JS, Lee KS, Kim JS, et al. Non-specific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195:645-648.
14. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-590.
15. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35:171-180.
16. Austin JH, Müller NL, Friedman PJ, et al. Glossary of terms for computed tomography of the lungs: recommendations of the nomenclature committee of the Fleischner society. Radiology 1996; 200:327-331.
17. Müller NL, Miller RR, Webb WR, Evans KG, Ostrow DN. Fibrosing alveolitis: CT-pathologic correlation. Radiology 1986; 160:585-588.
18. Müller NL, Staples CA, Müller RR, Vedal S, Thurlbeck WM, Ostrow DN. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987; 165:731-734.
19. Collins CD, Wells AU, Hansell DM, et al. Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography. Clin Radiol 1994; 49:236-240.
20. Wells AU, Hansell DM, Corrin B, et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992; 47:738-742.
21. Streiner DL, Norman GR. In: Streiner DL, Norman GR, eds. Health measurement scales: a practical guide to the development and use. Oxford, England: Oxford University Press, 1989; 94-95.
22. Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ 1992; 304:1491-1494.
23. Chinn S. Repeatability and method comparison. Thorax 1991; 46:454-456
24. Colby TV, Carrington CB. Interstitial lung disease. In: Thurlbeck WM, Churg AM, eds. Pathology of the lung. New York, NY: Thieme, 1995; 589-737.
25. Young RH, Mark GJ. Pulmonary vascular changes in scleroderma. Am J Med 1978; 64:998-1004.
26. Silver RM, Miller KS. Lung involvement in systemic sclerosis. Rheum Dis Clin North Am 1990; 16:199-216.
27. Wells AU, Cullinan P, Hansell DM, et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1994; 149:1583-1590.
28. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164:1182-1185.
29. Katzenstein AL, Fiorelli RF. Non-specific interstitial pneumonia/fibrosis: histologic features and clinical significance. Am J Surg Pathol 1994; 18:136-147.
30. Nicholson AG, Colby TV, Wells AU. Histopathological approach to patterns of interstitial pneumonias in patients with connective tissue disorders. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19:10-17.
31. Schurawitzki H, Stiglbauer R, Graninger W, et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 1990; 176:755-759.
32. Johkoh T, Ikezoe J, Kohno N, et al. High-resolution CT and pulmonary function tests in collagen vascular disease: a comparison with idiopathic pulmonary fibrosis. Eur J Radiol 1994; 18:113-121.
33. Wells AU, Hansell DM, Rubens MB, et al. Fibrosing alveolitis in systemic sclerosis: bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med 1994; 150:462-468.
34. Chan TY, Hansell DM, Rubens MB, du Bois RM, Wells AU. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans. Thorax 1997; 52:265-270.
35. Wells AU, Hansell DM, Rubens MB, Cailes JB, Black CM, du Bois RM. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison. Am J Respir Crit Care Med 1997; 155:1657-1664.
36. Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000; 162:2213-2217.
37. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157:199-203.
38. Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstital pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999; 160:899-905.
39. Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns-survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000; 24:19-33.
40. King TE Jr, Schwarz MI, Brown K, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001; 164:1025-1032.